d-alpha tocopherol has been researched along with ritonavir in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 1 (10.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Azzi, A; Munteanu, A; Ricciarelli, R; Zingg, JM | 1 |
| Munteanu, A; Ricciarelli, R; Zingg, JM | 1 |
| Bradshaw, EL; Bruce-Keller, AJ; Everson, WV; Greenberg, RN; Guerin, T; Guo, L; Li, XA; Ross, SA; Smart, EJ; Wilson, ME | 1 |
| Massone, S; Munteanu, A; Ricciarelli, R; Zingg, JM | 1 |
| Chao, Y; Grigorian, A; Hurford, R; Langford, TD; Patrick, C | 1 |
| Azzi, A; Guo, W; Meydani, M; Zingg, JM | 1 |
| Firmino, AV; Itinoseki Kaio, DJ; Luzia, LA; Rondó, PH; Santos, SS; Souza, JM | 1 |
| Indulkar, AS; Lou, X; Taylor, LS; Zhang, GGZ | 1 |
1 review(s) available for d-alpha tocopherol and ritonavir
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
9 other study(ies) available for d-alpha tocopherol and ritonavir
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
CD36 overexpression in ritonavir-treated THP-1 cells is reversed by alpha-tocopherol.
Topics: alpha-Tocopherol; Base Sequence; CD36 Antigens; Cell Line; Cholesterol; DNA Primers; HIV Protease Inhibitors; Monocytes; Proteasome Inhibitors; Ritonavir; RNA, Messenger | 2005 |
HIV protease inhibitors-induced atherosclerosis: prevention by alpha-tocopherol.
Topics: alpha-Tocopherol; Arteriosclerosis; Blotting, Western; CD36 Antigens; Cell Line, Tumor; Cell Separation; Cholesterol; Flow Cytometry; HIV Protease Inhibitors; Humans; Phospholipids; Proteasome Endopeptidase Complex; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir; Ubiquitin; Up-Regulation; Vitamin E | 2004 |
Nucleoside reverse transcriptase inhibitors prevent HIV protease inhibitor-induced atherosclerosis by ubiquitination and degradation of protein kinase C.
Topics: alpha-Tocopherol; Animals; Antioxidants; Atherosclerosis; CD36 Antigens; Cholesterol; Didanosine; Enzyme Activation; HIV Infections; HIV Protease Inhibitors; Humans; Macrophages; Mice; Mice, Knockout; Protein Kinase C-alpha; Receptors, LDL; Reverse Transcriptase Inhibitors; Ritonavir; Stavudine; Ubiquitin | 2006 |
Modulation of proteasome activity by vitamin E in THP-1 monocytes.
Topics: Cell Line; Cyclin-Dependent Kinase Inhibitor p27; Humans; Intracellular Signaling Peptides and Proteins; Leupeptins; Monocytes; Oxidative Stress; Protease Inhibitors; Proteasome Endopeptidase Complex; Ritonavir; Tocopherols; Tocotrienols; Tumor Suppressor Protein p53; Tyrosine; Vitamin E | 2007 |
Alterations in the Notch4 pathway in cerebral endothelial cells by the HIV aspartyl protease inhibitor, nelfinavir.
Topics: Aspartic Acid Endopeptidases; Cell Survival; Cells, Cultured; Cerebral Arteries; Cerebral Veins; Endothelial Cells; Frontal Lobe; HIV Protease Inhibitors; Humans; Indinavir; Nelfinavir; Oxidative Stress; Phosphorylation; Proto-Oncogene Proteins; Reactive Oxygen Species; Receptor, Notch1; Receptor, Notch4; Receptors, Notch; Repressor Proteins; Ritonavir; Saquinavir; Vitamin E | 2008 |
Alpha-Tocopherol counteracts ritonavir-induced proinflammatory cytokines expression in differentiated THP-1 cells.
Topics: alpha-Tocopherol; Antioxidants; Cell Differentiation; Cell Line; Chemokine CCL2; Cytokines; Gene Expression; Humans; Interleukin-6; Interleukin-8; Macrophages; Reverse Transcriptase Polymerase Chain Reaction; Ritonavir | 2007 |
Vitamin E concentrations in adults with HIV/AIDS on highly active antiretroviral therapy.
Topics: Acquired Immunodeficiency Syndrome; Adult; alpha-Tocopherol; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Cholesterol; Female; HIV Infections; HIV Protease Inhibitors; Humans; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Ritonavir; Vitamin E; Vitamin E Deficiency | 2014 |
Role of Surfactants on Release Performance of Amorphous Solid Dispersions of Ritonavir and Copovidone.
Topics: Drug Compounding; Drug Liberation; Hexoses; HIV Protease Inhibitors; Kinetics; Polysorbates; Pyrrolidines; Ritonavir; Solubility; Surface-Active Agents; Vinyl Compounds; Vitamin E | 2022 |